---
title: Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma
date: '2024-08-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39164890/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240821183036&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Our study confirms that the non-canonical NF-κB axis LTβ/NIK/RelB
  drives cholangiocarcinogenesis and represents a candidate therapeutic ...'
disable_comments: true
---
CONCLUSIONS: Our study confirms that the non-canonical NF-κB axis LTβ/NIK/RelB drives cholangiocarcinogenesis and represents a candidate therapeutic ...